CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
Orlando, Florida, United States and 85 other locations
which contains populations of CD8+ T cells targeting multiple leukemia associated antigen peptides in patients with Acute Myeloid...
Phase 1, Phase 2
Orlando, Florida, United States and 4 other locations
VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...
Phase 3
Orlando, Florida, United States and 180 other locations
). Both parts will be conducted in participants with previously untreated CD123+ AML who are ineligible for intensive chemotherapy....
Phase 2
Orlando, Florida, United States and 32 other locations
combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute...
Phase 3
Kissimmee, Florida, United States and 277 other locations
drug cusatuzumab added to venetoclax and azacitidine works to treat acute myeloid leukemia (AML) compared to vene...
Phase 2
Orlando, Florida, United States and 30 other locations
with intensive chemotherapy in participants with newly diagnosed acute myeloid leukemia (AML) harboring alteratio...
Phase 1
Orlando, Florida, United States and 39 other locations
A treatment cycle is 28 days for Cycle 1 and Cycle 2. Tagraxofusp will be administered at 12 mcg/kg IV over 15 minutes (-5 or +15 minutes) daily for...
Phase 2
Orlando, Florida, United States and 6 other locations
Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2, 3, or 4 prior in...
Phase 3
Orlando, Florida, United States and 38 other locations
Clinical trials
Research sites
Resources
Legal